FindTrial
Sign In

Comparison between plain bupivacaine, bupivacaine with nalbuphine and bupivacaine with buprenorphine in spinal anaesthesia

A COMPARATIVE STUDY OF EFFECTS OF PLAIN BUPIVACAINE, BUPIVACAINE WITH NALBUPHINE AND BUPIVACAINE WITH BUPRENORPHINE IN SPINAL ANAESTHESIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040260
Enrollment
90
Registered
2022-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Control Intervention1: Group A - Buprenorphine: Buprenorphine is a centrally acting partial opioid agonist with both spinal and supraspinal component of analgesia. It has a loc

Sponsors

DR Prem Sagar
Lead Sponsor
Basaveshwar Teaching And General Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS UNDERGOING ELECTIVE LOWERLIMB SURGERIES. AMERICAN SOCIETY OF ANAESTHESIOLOGIST(ASA) GRADE I & II.

Exclusion criteria

Exclusion criteria: PREGNANCY. PATIENTS WITH ALLERGY TO DRUG UNDER STUDY. PATIENTS WITH SPINAL DEFORMITIES. SUBJECTS HAVING CONTRAINDICATIONS FOR SPINAL ANAESTHESIA

Design outcomes

Primary

MeasureTime frame
To Study The Onset , Duration Of Sensory And Motor Blockade And Any Adverse Effects Of The Given Drug Intrathecally. Timepoint: To Study The Onset , Duration Of Sensory And Motor Blockade And Any Adverse Effects Of The Given Drug Intrathecally.—

Secondary

MeasureTime frame
To Study Any Adverse Effects Of Drugs In Post-Operative PeriodTimepoint: From The Time Of Injection to 24Hours Of Time—

Countries

India

Contacts

Public ContactDR MD YAHYA

MAHADEVAPPA RAMPURE MEDICAL COLLEGE

dr.yahya.imran@gmail.com9845119760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026